Log in

View Full Version : Articles of Interest


Pages : 1 2 3 4 5 6 7 8 [9] 10 11 12 13 14 15 16 17 18

  1. Super cells fight cancer (0 replies)
  2. Bone drugs may raise risk of irregular heartbeat (0 replies)
  3. Traditional Herbal Medicine Kills Pancreatic Cancer Cells (0 replies)
  4. Blood Pressure Drugs Halt Pancreatic Cancer Cell Growth (0 replies)
  5. Chinese botanical PHY906 plus cap (0 replies)
  6. receptor found to be resistant to Tamoxifen (0 replies)
  7. Anemia may be helpful (0 replies)
  8. Activity cuts breast cancer risk (0 replies)
  9. Androgens may play a role in breast cancer development (0 replies)
  10. Side Effects of Hormone Therapy May Signal Success (0 replies)
  11. Polysomy 17 and impact on Her2 testing (2 replies)
  12. MarginProbe in bc surgery (0 replies)
  13. link between alcohol and breast cancer (0 replies)
  14. 3D ultrasound distinguishes malignant from benign breast masses (0 replies)
  15. effect of green tea and Ganoderma lucidum on (met) breast cancer cells (1 replies)
  16. hepatic intra-arterial paclitaxel to liver mets (0 replies)
  17. Global gene expression profile of LCIS created (0 replies)
  18. Good Article on Memory Problems (0 replies)
  19. Phthalates disrupt male fetal development (0 replies)
  20. Bisphenol A confers chemoresistance in breast cancer cells in culture (0 replies)
  21. FDA Vetting Process for MammoSite controversial (0 replies)
  22. Purple Tomato Extended Lives of Cancer-Prone Mice (0 replies)
  23. The best cancer-fighting foods (0 replies)
  24. Eating Fruit And Vegetables Can Improve Cancer Patients' Response To Chemotherapy (0 replies)
  25. Three "Inconvenient Truths" About Health Care (0 replies)
  26. Novel image analysis application to measurement of ER and PR receptor levels in bc (0 replies)
  27. Several factors increase surgical site infection risk after breast operation (0 replies)
  28. Current HRT use is associated with low-grade breast cancer tumors (0 replies)
  29. A candidate molecular signature associated with tamoxifen failure in primary bc (0 replies)
  30. Molecular changes in cells occur before morphological alterations in IDC (0 replies)
  31. Targeting aspartate aminotransferase in breast cancer (0 replies)
  32. Calcium and vitamin D show no benefit against pre-breast cancers (1 replies)
  33. Lumpectomy for Breast Cancer Recurrence May Reduce Survival (0 replies)
  34. Herb artemisinin kills cancer (2 replies)
  35. Monthly vitamin D3 supplementation safe and effective (0 replies)
  36. YB-1 is a stronger predictor of relapse and survival than ER receptor or Her2 (0 replies)
  37. Breast Cancer Cells Recycle To Escape Death By Hormonal Therapy (0 replies)
  38. Strong Syergy Of.... (0 replies)
  39. New testing for CTC (0 replies)
  40. Soy's protective effect against breast cancer varies by receptor status (2 replies)
  41. High blood flow to breast cancer tumors linked to high recurrence risk (0 replies)
  42. help protect bones from breaking with high levels vit c (0 replies)
  43. Cancer fighting human immune cells to be grown in pigs (0 replies)
  44. Caffeine Consumption Shown Not To Increase Overall Breast Cancer Risk (0 replies)
  45. Jellyfish protein spawns revolution in biology (0 replies)
  46. Endoscopic Surgery for Early Breast Cancer May Improve Aesthetic Results (0 replies)
  47. LHRH agonists may be useful in premenopausal breast cancer (0 replies)
  48. Breast cancer mortality falls soon after start of screening programs (0 replies)
  49. Researchers: Jam, Jelly Have Cancer-Fighting Powers (2 replies)
  50. Recurrence dynamics does not depend on the recurrence site (3 replies)
  51. Genetic test from Iceland discussion (0 replies)
  52. Midlife Bone Fracture Indicates Increased Risk of Male BC (1 replies)
  53. Study: Aspirin/Ibuprofen May Cut BC Risk (0 replies)
  54. Ip6 (1 replies)
  55. S-1 (Japan) (0 replies)
  56. mid year update on her2 drugs by ... (0 replies)
  57. mid year update on her2 drugs by ... (2 replies)
  58. Walnuts Slow Growth of Breast Cancer Tumors (7 replies)
  59. Vaccine within reach, says expert (0 replies)
  60. Mamma Print (0 replies)
  61. Those darn cancer cells know how to fool and switch to survive... (0 replies)
  62. Stopping Treatment Can Reverse Acquired Resistance to Letrozole (1 replies)
  63. Being a Bad Patient Can Save Your Life (5 replies)
  64. Single Reading with Computer-Aided Detection for Screening Mammography (0 replies)
  65. Analyzing effects of extra-virgin olive oil polyphenols... (2 replies)
  66. Biphosphonates Risk- Crappy For Many Bones (0 replies)
  67. Diet Supplement Negates Breast Cancer Drug Action (0 replies)
  68. Acupuncture reduces endocrine therapy side effects in breast cancer (0 replies)
  69. Near Infrared Nanoparticles Shine A Bright Light On Cancer (0 replies)
  70. Quality of life for 5-year breast cancer survivors similar to general population (3 replies)
  71. Phosphorylated EGFR and PI-3K/Akt signaling kinases are expressed in ctcs of bc pts (0 replies)
  72. Herpes Shows Promise for Killing Cancer (2 replies)
  73. for RB--more complexity (1 replies)
  74. Allergic reactions to lymphatic dyes (SNB) can be delayed and severe (0 replies)
  75. For RB - Omega 6 Intake tied to BC Risk (1 replies)
  76. her2 converts to negative? (0 replies)
  77. Classification of ER+ Her2+ breast tumors open to debate (0 replies)
  78. Yanhusuo extract inhibits metastasis of breast cancer cells (0 replies)
  79. NJEM Editorial: Identifying and Addressing Safety Signals in Clinical Trials (0 replies)
  80. NJEM correspondence: Zoledronic Acid Infusion and Orbital Inflammatory Disease (0 replies)
  81. Preoperative Endocrine Prognostic Index identifies ER+ pts who can avoid chemo (0 replies)
  82. Probable hepatotoxicity and trastuzumab (0 replies)
  83. Hope over new breast cancer vaccine (1 replies)
  84. Most Cancer Treatment Studies Aren't Published, Study Finds (0 replies)
  85. Post-mastectomy nodal radiation unnecessary for node-negative breast cancer (0 replies)
  86. Clodronate Lowers Long-Term Risk of Osteoporosis in Early Breast Cancer Patients (0 replies)
  87. MRI scan could determine need for rads (0 replies)
  88. Radiation tx post mastectomy (0 replies)
  89. Shorter Radiation Course Works in Breast Cancer (0 replies)
  90. Long-term menopausal hormone therapy is associated w/favorable tumor characteristics (0 replies)
  91. Please Pardon My Chemo Brain... (0 replies)
  92. new option in Radation...performed in SD (0 replies)
  93. Well, this is good news... (3 replies)
  94. I was very moved by this article of supporitve sisters (0 replies)
  95. Evolving Role of ER receptor Beta in clinical BC - editorial (0 replies)
  96. New Real-Time Imaging Technique Captures Cell Movements In Mouse Model Of BC (0 replies)
  97. her2+ bc with lymphocytes relapses less... (4 replies)
  98. Lifestyle changes and telomerase (0 replies)
  99. Hey sister's ! Do you any of you know of (1 replies)
  100. Stem Cells May Solve Mystery Of Early Pregnancy Breast Cancer Protection (0 replies)
  101. HSP70 - 'Black sheep protein' key to cancer cell death (1 replies)
  102. Scientists discover how to isolate stem cells in tumors (0 replies)
  103. Zometa Boosts Survival... (1 replies)
  104. treatment with encapulated form of doxorubicin (0 replies)
  105. Taxotere show benefit in early stage bc. (1 replies)
  106. New compound turns 'good' viruses into 'magic bullet' to kill cancer cells (0 replies)
  107. Multitargeted therapy of cancer by silymarin(milk thistle). (4 replies)
  108. Translating bc stem cell markers into clinical practice - editorial (0 replies)
  109. ER alpha-status of disseminated tumor cells in bone marrow of primary bc patients (5 replies)
  110. Pegylated Liposomal Doxorubicin Beneficial In Metastatic Breast Cancer (0 replies)
  111. Psychological Distress May Increase Risk of Breast Cancer (0 replies)
  112. Human Endogenous Retroviruses - possible relation to cancer (0 replies)
  113. Vytorin and Cancer - is there a link? (1 replies)
  114. Vaccine against HER2-positive breast cancer offers complete protection in lab (1 replies)
  115. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-der (8 replies)
  116. BioCancell: guided missile that explodes in the cancer cell (1 replies)
  117. Interview with Dr. Dennis Slamon (1 replies)
  118. The functional loss of the retinoblastoma tumor suppressor is a common event in Basal (0 replies)
  119. Sorafenib may resensitize metastatic ER+ bc to AI's (0 replies)
  120. Pretherapy coagulation markers predict VTE risk in breast cancer (0 replies)
  121. Erbitux, Celebrex & experimental anti-inflammatory (real?) (0 replies)
  122. APATONE: applicable to BC? (1 replies)
  123. Absorption of Lapatinib (3 replies)
  124. IGF inhibitor enhances effacy of Herceptin (1 replies)
  125. Scientists map the domino effect of gene changes that trigger lethal brain, pancreati (0 replies)
  126. ovarian abalatioin upregulates her2 (4 replies)
  127. benefits of giving zoledronic acid after doxorubicin (3 replies)
  128. Change in Her2 Status May Explain Waning Response to Herceptin (0 replies)
  129. ER Beta positivity significant in node positive bc (0 replies)
  130. Oxidative Stress and the development of agressive ER+ bc (4 replies)
  131. Gene test for good prognosis ER- bc in the works (0 replies)
  132. Anastrozole Does Not Impair Cognition as Breast Cancer Preventative (0 replies)
  133. Researchers See Promise in New Test for Tumors (0 replies)
  134. Laser for brain mets (0 replies)
  135. Laser for brain mets (0 replies)
  136. Activity Key to Breast Cancer Survival (2 replies)
  137. Radiation and timing Effects on development of her2 bc (0 replies)
  138. Latest Issue of Breast Cancer Update for Oncologists (0 replies)
  139. Her2 BC more associated with early menarche (6 replies)
  140. Body size and risk (0 replies)
  141. BRCA1-breast cancer gene network discovered (0 replies)
  142. Obesity is most important lifestyle factor in breast cancer outcome (0 replies)
  143. Health related quality of life after combined hormone replacement therapy: randomised (0 replies)
  144. 'Cutting By Color': New Imaging Technique For More Precise Cancer Surgery (0 replies)
  145. Testosterone use (0 replies)
  146. soy with genistein may lower her2 (0 replies)
  147. Sniffing out cancer (0 replies)
  148. Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumorigenesis in mice (0 replies)
  149. Timing of radiotherapy does not influence (local) breast cancer relapse (0 replies)
  150. COX2 expression linked to early bone spread in breast cancer (0 replies)
  151. For Those To Take Curcumin Supplements.... (14 replies)
  152. Doxorubicin-Zoledronic Acid Sequence Effective Against Experimental Breast Cancer (0 replies)
  153. Influence of Pre- and Postdiagnosis Physical Activity on Mortality in Breast Cancer S (0 replies)
  154. tears vs. mammos- and other topics (0 replies)
  155. Exercise in lab rats elucidates bc pathways (0 replies)
  156. Effect of Prediagnostic Alcohol Consumption on Survival after BC in Young Women (1 replies)
  157. B-Vitamin Intake, One-Carbon Metabolism, and Survival in a Population-Based Study of (0 replies)
  158. Red meat intake during adolescence poses breast cancer risk (0 replies)
  159. history of environmental estrogn release (10 replies)
  160. Researchers tie skin creams to cancer in mice (0 replies)
  161. HER-2 antibody therapy cost-effective for metastatic breast cancer (0 replies)
  162. Risk Assessment....article. (0 replies)
  163. Dedicated Breast CT Scanners More Comfortable Than Mammography (0 replies)
  164. Breast cancer growth shows circadian rhythm (1 replies)
  165. Targeted Radiation for limited mets (1 replies)
  166. Breast cancer recurrence seen as low after 5 years (0 replies)
  167. Aussie discovery with potential (0 replies)
  168. Prolactin inhibitor augments chemotherapy for breast cancer (0 replies)
  169. 21-gene assay predicts breast cancer relapse better than Adjuvant! (0 replies)
  170. Estrogen receptor modification is marker of treatment response (0 replies)
  171. Comparison of molecular phenotypes of DCIS and invasive breast cancer (0 replies)
  172. Prognosis of secondary breast cancers 'generally good' (3 replies)
  173. AC vs AT 0 to 3 Positive Nodes (0 replies)
  174. Phase 2 Clinical Trial (0 replies)
  175. Iron imbalance may affect bc incidence and recurrence (0 replies)
  176. ER-β status predicts breast cancer outcome independent of ER- α (0 replies)
  177. MRI Diagnostic Workstation Differentiates Breast Tumor Subtypes (0 replies)
  178. Hypertension potentiates the risk of doxorubicin cardiotoxicity (3 replies)
  179. Lapatinib effectiveness against brain mets studied in mice (0 replies)
  180. Drug gives couch potato mice benefits of a workout (0 replies)
  181. Breast carcinoma in situ patients face later invasive cancer risk (0 replies)
  182. The Story Behind Kennedy’s Surgery (0 replies)
  183. Role of HPV in breast cancer still unclear (0 replies)
  184. Histologic grade predicts outcome in lobular breast cancer (0 replies)
  185. Breast Cancer Survival Drops With Increasing Body Mass Index (0 replies)
  186. bone density and increased risk (1 replies)
  187. Not specifically bc, but important info about granite counter tops (1 replies)
  188. Alternative To Mammograms Under Study (0 replies)
  189. Delayed and immediate ALND equivalent for early breast cancer (0 replies)
  190. Family history not a predictor of early onset breast cancer (0 replies)
  191. Epigenetic mapping and functional analysis in a breast cancer metastasis model (0 replies)
  192. Genes responsive to both oxidant stress and loss of ER function identify poor prognos (0 replies)
  193. Continuing Trastuzumab beyond disease progression: outcomes analysis (0 replies)
  194. Omega-6 fatty acids contribute to the incidence of breast cancer in postmeno women (1 replies)
  195. Protective effect of soy against breast cancer risk differs by receptor status (1 replies)
  196. Tumor blood flow, metabolism predicts advanced breast cancer survival (0 replies)
  197. Study of 31 Countires regarding survival rates. (0 replies)
  198. Estrogen receptor complex has dual action in breast cancer (0 replies)
  199. Lapatinib Appears Safe in Patients With Breast Cancer (0 replies)
  200. Kind of like...walk the dog (cancer cells)...cool apporach (0 replies)
  201. Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet (0 replies)
  202. Reconsidering the value of LVI (0 replies)
  203. Alcohol intake associated with modest bc survivial benefit (0 replies)
  204. Value of self-examination questioned for breast cancer mortality (0 replies)
  205. New sentinel node test more accurate than standard for breast cancer staging (0 replies)
  206. Commentary:False-Positive Results in Cancer Epidemiology (0 replies)
  207. Common SNPs do not substantially improve breast cancer risk prediction (0 replies)
  208. Unususal sites for metastases do not confer added risk of death (0 replies)
  209. Discovery Of Mechanism Explains How Cancer Enzyme Winds Up On Ends Of Chromosomes (0 replies)
  210. Cookbooks or recipe website? (1 replies)
  211. virus helps detect metastases much earlier (0 replies)
  212. 100 Best Cancer Centers (0 replies)
  213. Smart bomb` nanoparticles stop cancer`s spread (1 replies)
  214. Research correlates alleles of obesity genes an bc risk (0 replies)
  215. letrozole and IGF-IR inhibitors synergistically induce apoptosis in lab models of bc (0 replies)
  216. Study Identifies Unique Biology of Breast Cancers Arising in Younger Women (1 replies)
  217. Soy-rich foods may protect against breast cancer (0 replies)
  218. new discovery about Herceptin; attacks stem cells... (2 replies)
  219. Antibody To Breast Cancer-Secreted Protein Blocks Metastasis (0 replies)
  220. 3D-conformal radiotherapy improves dosimetry for breast cancer (0 replies)
  221. CK19 mRNA expression identifies lymph node metastases intraoperatively (0 replies)
  222. tykerb promising for advanced ErbB2-amplified breast cancer (0 replies)
  223. FDA Approves Her2 Breast Cancer Test (0 replies)
  224. Tumor size is unreliable predictor of survival in basal-like breast cancers (0 replies)
  225. Vitamin D receptor variant linked to early onset breast cancer (2 replies)
  226. Court ruling threatens patients rights to sue over drug injuries (0 replies)
  227. Investigational Drug Combination Plus Chemotherapy Promising in BC Cell Lines (0 replies)
  228. New Oral Angiogenesis Inhibitor Offers Potential Nontoxic Therapy For A Wide Range Of (2 replies)
  229. 2008 Miami Breast Cancer Conference materials on line (0 replies)
  230. Polygenes, Risk Prediction, and Targeted Prevention of Breast Cancer (0 replies)
  231. Radiotherapy beneficial for stage II breast cancer with lymph node disease (0 replies)
  232. Medicare issue, congress, docs, and patients (1 replies)
  233. Responding to same endocrine treatment again. (3 replies)
  234. Six Weeks Of Radiation Therapy May Be Unnecessary For Many Breast Cancer Patients (0 replies)
  235. Dietary phytoestrogen inhibits angiogenesis in breast cancer models (0 replies)
  236. Outreach program helps catch breast cancer early in African-American women (0 replies)
  237. Large proportion of breast cancers preventable by lifestyle changes (0 replies)
  238. 5 genes involved in metastus if breast tumours (0 replies)
  239. Cognitive problems of breast cancer chemotherapy resolve after a year (1 replies)
  240. For Some Patients, Cancer Is Just Half The Battle (2 replies)
  241. Non toxic treatment (I am certain we will be seeing more of these) (0 replies)
  242. Vit. D supplement has not been updated by the FDA since 1997 (1 replies)
  243. trying to get the answers to cell behavior (0 replies)
  244. Absence of CHFR gene leads to genomic instability and breast cancer (0 replies)
  245. Detecting Breast Cancer With Hair (0 replies)
  246. Guidelines for the Management of Brain Mets (3 replies)
  247. The role of predictive factors in guiding treatment decisions (0 replies)
  248. Ovarian Stimulation With Letrozole Does Not Raise Breast Cancer Recurrence Risk (0 replies)
  249. Axillary lymph node recurrence rare following SNLB (0 replies)
  250. Her2 Has Less Prognostic Value in IBC (0 replies)